Applicant, as named in the Orange Book
Mylan Speciality Lp
Products with listed protection
| Drug | Ingredient | NDA | Earliest generic entry | Basis |
|---|
None.
Recent events
- 25 Oct 2026Rowasa · Generic approved 31 Mar 2026
- 24 Oct 2026Sfrowasa · Enters 12-month window basis: patent24 Jul 2027
Products without listed protection (5)
| Drug | Ingredient | NDA | Earliest generic entry | Basis |
|---|
| Depen penicillamine | penicillamine | 019854 | open now | no listed protection |
| Dymista azelastine hydrochloride; fluticasone propionate | azelastine hydrochloride; fluticasone propionate | 202236 | open now | no listed protection |
| Felbatol · 2 strengths felbamate | felbamate | 020189 | open now | no listed protection |
| Rowasa mesalamine | mesalamine | 019618 | open now | no listed protection |
| Soma · 2 strengths carisoprodol | carisoprodol | 011792 | open now | no listed protection |